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OBJECTIVE: Temporal processing refers to the ability of the central auditory nervous system to encode and
detect subtle changes in acoustic signals. This study aims to investigate the temporal resolution ability of
individuals with mesial temporal sclerosis and to determine the sensitivity and specificity of the gaps-in-noise
test in identifying this type of lesion.
METHOD: This prospective study investigated differences in temporal resolution between 30 individuals with
normal hearing and without neurological lesions (G1) and 16 individuals with both normal hearing and mesial
temporal sclerosis (G2). Test performances were compared, and the sensitivity and specificity were calculated.
RESULTS: There was no difference in gap detection thresholds between the two groups, although G1 revealed
better average thresholds than G2 did. The sensitivity and specificity of the gaps-in-noise test for neurological
lesions were 68% and 98%, respectively.
CONCLUSIONS: Temporal resolution ability is compromised in individuals with neurological lesions caused by
mesial temporal sclerosis. The gaps-in-noise test was shown to be a sensitive and specific measure of central
auditory dysfunction in these patients.
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Temporal processing refers to the ability of the central
auditory nervous system (CANS) to encode and detect
subtle changes in acoustic signals, and normal temporal
processing is necessary for perception of these acoustic
changes (1-3). This processing has been further identified as
being critical for normal auditory development (4). In the
clinic, temporal processing can be evaluated behaviorally
through measures such as the gaps-in-noise (GIN) test. This
test was developed by Musiek in 2005 to characterize the
ability of the CANS to resolve very brief acoustic changes.
In particular, patients participating in the test are asked to
press a button as quickly as possible as soon as a brief gap
in a noise burst is identified (3).
The utility of the GIN test has been examined internation-
ally in a variety of different populations (3,5-11). In North
America, normal-hearing individuals present gap detection
thresholds (GDThs) of approximately 5 ms (4.8 ms for the
left ear and 4.9 ms for the right ear) (3). Other researchers
have also noted that GDThs of approximately 5 ms, with
no significant differences between ears (7). Similar thresholds
have been found in other normal-hearing (10) adults as in
the previous studies (7). Examining non-neurological
clinical groups, Sanches and colleagues found increased
GDThs in individuals with tinnitus and normal peripheral
hearing compared with normal-hearing individuals without
tinnitus (10). This finding suggests that individuals with
tinnitus may have alterations in their temporal resolution
ability.
The GIN test has also been studied in patients with CANS
involvement to characterize the temporal resolution ability of
these individuals as well as to compute sensitivity and
specificity because the GIN test is considered to be more
sensitive for cortical lesions than other tests are (12). Findings
have indicated that individuals with CANS lesions show
deficits in their temporal resolution ability, as revealed by
elevations in GDThs and decreases in the number of correctly
identified gaps (3,5,13). Furthermore, clinical decision analysis
has indicated that the test has good sensitivity and specificity,
particularly for patients with cortical lesions (3,5,13).
One clinical group with neurological dysfunction of the
CANS that has not been widely investigated with the GIN
test comprises patients with mesial temporal sclerosis (MTS).
MTS is the most common cause of temporal lobe epilepsy.DOI: 10.6061/clinics/2015(09)02
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All patients with MTS have neuronal loss and atrophy, but
cortical dysplasia is present in only 15% of the cases. Certain
studies have also shown a decreased gray-white matter
demarcation in the temporal lobe parenchyma (14). As the
temporal lobe is a region that is highly related to auditory
processing, changes in this area may affect the auditory skills
of these patients.
It is well known that MTS patients have problems with
certain auditory abilities in daily life, such as speech percep-
tion acuity and speech discrimination; the GIN detection test
has been found to be useful for assessing these difficulties
(15-17).
The objectives of the present study were to first describe
the temporal resolution ability of individuals with possible
neurological CANS involvement caused by MTS and to then
compute the sensitivity and specificity of the GIN test in this
specific neurological population. We hypothesized that
individuals with this disorder would show increased GDThs
on the GIN test and that the test would reveal a good balance
between sensitivity and specificity (i.e., good test efficiency).
’ MATERIALS AND METHODS
Participants
A total of 46 individuals were evaluated and divided into
two groups: group 1 (G1; control group) was composed of
30 individuals with normal hearing sensitivity and without
hearing disorders or a neurological disorder (mean age of
24.9 years; standard deviation (SD)=3.3), and the neurologi-
cal group, or group 2 (G2), included 16 individuals with MTS
in either the right lobe (N=14) or the left lobe (N=2
individuals) (mean age of 38.9 years; SD=9.3). All individuals
showed normal results for a standard audiological evalua-
tion, with pure-tone thresholds at the octave frequencies
from 250 through 8000 Hz, equal to 20 dB HL or better;
normal speech recognition test results; and normal tympa-
nometry. None of the subjects in either group had auditory
symptoms. Additionally, no significant air-bone gaps or
interaural threshold differences greater than 10 dB were
observed. The inclusion criteria for the different groups were
as follows: subjects in G1 had negative neurological histories
and performances within the normal limits on the dichotic
digits and duration pattern tests (18-20), and subjects in G2
had a diagnosis of MTS confirmed by imaging exams (fMRI)
of the temporal regions (excluding the brainstem) in the right
or left hemisphere and performances below the normal limits
on the dichotic digits and duration pattern tests.
Procedures
The study design and consent form were approved by the
University Ethics Committee for the Analysis of Research
Projects (protocol number 1126/05). Subjects were submitted
to the following procedures: a case history interview, pure-
tone audiometry, speech recognition tests, tympanometry,
acoustic reflex tests, and the GIN test (3). All testing was
conducted by the staff of the Speech-Language Pathology
and Audiology Laboratory of Investigation in Auditory
Processing of the SLP and Audiology Program.
Description of the GIN Test
The GIN test is a CD-based measure that can be
administered in a typical audiology clinic. In the present
study, the test was administered in a sound-proof booth
using a GSI-61 audiometer and a Sony CD player. The test
stimuli were presented at an intensity of 50 dB SL above the
pure-tone average at 0.5, 1, and 2 kHz. The test was always
presented monaurally, with both ears being tested separately.
The CD features one practice list and four test lists; each
subject completed the practice list before beginning the
experiment. A different test list was presented to each ear
during the experiment, with one in the right ear and another
in the left ear.
In the GIN test, subjects identify when gaps occur in a
noise stimulus. The noise is a Gaussian-distributed white
noise generated with a sampling rate of 44.1 kHz. Noise
segments are 6 s in duration, within which 0 to 3 gaps may
be embedded. The gap durations are 2, 3, 4, 5, 6, 8, 10, 12, 15,
and 20 ms. In each GIN list, the individual gap durations are
presented 6 times each in random locations across the
various trials, for a total of 60 gaps. Moreover, certain noise
trials do not contain any gaps. The shortest time interval
between gaps in a noise burst is 500 ms, and the longest
interval is on the order of seconds. Each trial is 6 s in
duration, during which the noise stimulus is presented, and
the interval between trials is 5 s. The four different GIN lists
have been shown to be equivalent (3,8).
In the present study, subjects were instructed to press the
response button as soon as they heard a gap. If a gap
occurred and the response button was not pressed, this was
counted as an error. If no gap occurred but the button was
pressed, it was counted as a false positive. The examiner
clarified any confusion regarding the responses by asking the
subject how many gaps were detected in that specific
segment to confirm the number of correct responses. The
approximate GDTh for each test list was defined as
the shortest gap perceived by the subject at least 66.6% of
the time, which was four times per list. If a subject’s
performance fluctuated by gap duration (e.g., 4 of 6 correct
at 4 ms, 2 of 6 correct at 5 ms, 4 of 6 correct at 6 ms), the gap
duration at which the performance stopped fluctuating was
considered as the GDTh (6 ms in the preceding example).
Normal performance on this test was defined by Samelli and
Schochat (7) as a GDTh of 4.19 ms and a correct identification
score of 78.5% or greater.
’ RESULTS
With respect to the age of the individuals, G2 (the
neurological group) showed a higher average age than G1
(the control group) did (averages: G1=25 years old and
G2=38 years old).
Table 1 shows the descriptive statistics for both groups’
GIN testing. The results are presented as the mean GDTh
Table 1 - Descriptive statistics for the gap detection






G1 – Normal 30 4.7 1.0 5
G2 – MTS 16 7.4 2.9 7
Group LE
G1 – Normal 30 4.6 1.0 5
G2 – MTS 16 8.1 1.7 8
Legend: RE = right ear; LE = left ear; N = total number of subjects;
G1 = group 1; G2 = group 2; MTS = mesial temporal sclerosis
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(in ms) and the percentage of correctly identified gaps. The
mean threshold obtained for G1 was significantly smaller
than that for G2 (po0.001), indicating better gap detection
performance in individuals without MTS. In both groups,
however, no significant difference was detected between the
left and the right ears (G1: p=0.227; G2: p=0.432). Addition-
ally, the mean percentage of correct data (Table 2) indicated
that G2 scored significantly more poorly than G1 did. Finally,
for the MTS group, a comparison of performance between
the ear ipsilateral to the lesion and the ear contralateral to the
lesion did not reveal a significant difference in the GDTh
(p=0.564) or the percentage of correct identification (p40.999)
(Table 3).
As stated previously, a second purpose of the present
study was to establish the sensitivity and specificity of the
GIN test in patients with MTS. To this end, receiver operating
characteristic (ROC) curves were created to characterize the
relationship between sensitivity and specificity for a variety
of different cut-off criteria. The optimal criteria were
assumed to be those that yielded the best balance between
sensitivity and specificity. Because no significant difference
was found between ears by comparing the thresholds, the
ears were grouped and averaged in the creation ROC curves
(Figure 1). Figure 2 shows the ROC curves for the percentage
of correct answers for the right and left ears. The most
efficient cut-off was 6.8 ms (e.g., X8 ms GDTh on the GIN),
at which the sensitivity was 68% and the specificity was 98%.
For the percentage of correct responses, for the right ear, the
most efficient cut-off was 70.6%, at which the sensitivity was
85% and the specificity was 73%. For the left ear, the most
efficient cut-off was 71%, at which the sensitivity was 78%
and the specificity was 73%.
’ DISCUSSION
The major results of the present study can be described as
follows: patients with MTS had significantly increased GDTh
values and lower percentages of correct gap detection than
neurologically normal controls did, indicating significant
impairments in temporal processing in this clinical popula-
tion; a GDTh criterion of X8 ms yielded the best balance of
sensitivity and specificity for MTS lesions (68% and 98%,
respectively); a percentage of correct identification of 70%
yielded the best balance between sensitivity and specificity
(approximately 80% and 73%, respectively); and no sig-
nificant difference was found in the GDTh or the percentage
of correct responses between ears in either group.
Comparison with Previous Literature on Normal-
Hearing and Neurological Populations
Regarding age, individuals in G2 were older than those in
G1 (averages: G1=25 years old and G2=38 years old).
However, recent studies on normal individuals from 21 to
45 years of age showed that there is no correlation between
adult subjects’ age and GIN test thresholds; in fact, the GDTh
was consistently 4.7 ms, suggesting that age does not affect
the GDTh in adults (10,21). Another study found an adult
GDTh of 5.43 ms (established by adding 2 SDs to the mean
GDTh) (7).
The findings of the present study are in good agreement
with results from previous studies investigating GIN test
performance in normal-hearing populations. Specifically,
normal-hearing listeners in one prior study (3) showed
GDTh values that were very similar to those noted in the
present study (B4.8 ms in their findings andB4.7 ms for the
left ear and B4.6 ms for the right ear in the present study)
(Table 1). Similarly, two other studies also noted mean GDTh
values in normal-hearing listeners (6,21), or 5 ms and 4.7 ms,
that were similar to those obtained in the present study. The
present findings further suggested that the ear did not affect
GIN test performance in the normal-hearing population,
corroborating a result of Samelli and Schochat (8). Regarding
the percentage of correct responses, in the current study, G1
also showed values that were similar to those reported in
other studies (3,8). In fact, only one study in the literature (7)
is incongruent with the results for normal listeners in the
present study; that study reported a GDTh value (4.19 ms)
smaller than that found in the present sample, although this
difference was not clinically meaningful. However, if we add
the SD to the mean, the obtained value is similar to the value
suggested by the study with normal criteria (5.43 ms).
Findings for subjects with confirmed CANS involvement
in the present study were also generally consistent with
Table 2 - Descriptive statistics for the percentage of correct





G1 – Normal 30 75.6 7.6 75
G2 – MTS 16 57.6 13 63.3
Group LE
G1 – Normal 30 76.1 7.6 76.6
G2 – MTS 16 52.7 13.1 55.8
Legend: RE = right ear; LE = left ear; N = total number of subjects;
G1 = group 1; G2 = group 2; MTS = mesial temporal sclerosis
Table 3 - Descriptive statistics for the thresholds and the
percentage of correct answers in the gaps-in-noise test
for the ipsilateral and contralateral ears.
Ear N Mean Standard
Deviation
Median
Ipsi (threshold) 16 7.5 2.9 8
Contra (threshold) 16 8.0 1.8 8
Ipsi (%) 16 56.7 12.7 59.2
Contra (%) 16 53.6 13.7 57.5
Figure 1 - Receiver operating characteristic curves for the gaps-in-
noise test threshold, comparing the normal and neurological
groups.
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previous studies. In particular, values similar to those
obtained in the current study were reported in the literature
(3), in which the GDThs obtained for individuals with CANS
disorders were 8.5 ms for the right ear and 7.8 ms for the left
ear. Furthermore, other research (5) noted that neurological
subjects had abnormal GDThs in both ears. The authors
specifically administered the GIN test to 8 individuals with
neurological dysfunction and noted abnormal performance
in all cases. Thresholds were bilaterally abnormal in five
cases (four with a right lesion and one with a left lesion) and
abnormal only in the ear contralateral to the lesion in three
cases (two with a left lesion and one with a right lesion). All
of the thresholds were between 6 ms (SD=2) and 9 ms (SD=1)
for the left ear and between 8 ms (SD=2) and 11 ms (SD=3)
for the right ear.
As found in our study, others researchers (22) showed
worse results in neurological patients. These researchers
studied gap detection in individuals with acquired aphasia
secondary to left hemisphere lesions using two different
mechanisms, or ‘‘within-channel’’ and ‘‘between-channel’’
conditions. The results showed that individuals with aphasia
averaged fewer correct responses than age-matched neuro-
logically intact controls did and that as the gap duration
increased, the mean number of correct responses increased in
both the control and the aphasic subjects. The results also
suggested that left hemisphere lesions prevent perceptual
discriminations that require the precise analysis of informa-
tion that unfolds or rapidly changes over time.
Based on these results, we can say that MTS patients
represent a clinical population that may clearly have an
auditory deficit. Audiologists also may see these patients and
should be aware that these patients could have central
auditory deficits. Audiologists should also be aware that a
normal pure-tone audiogram in patients with MTS may not
reveal the whole story.
Lack of Laterality in the Present Findings
Because our study group was small (only 14 individuals
with right MTS and 2 with left MTS), it is difficult to affirm
that the side of the lesion influences GIN test performance.
Although a numerical trend indicated that the ear
contralateral to the lesion scored more poorly than the ear
ipsilateral to the lesion did, this difference did not reach
statistical significance (Table 3). This finding is somewhat
consistent with previous research, which has also indicated
that no significant laterality effects exist in neurological
populations. For instance, poorer GDTh values are not
always observed in the ear contralateral to the injured
hemisphere (23). Furthermore, another study (3) noted that
only four of eighteen individuals in a sample of neurological
patients demonstrated a contralateral ear effect, and no
significant within-group differences were found for the left
ear compared with the right ear for the GDTh or for the
percentage of correct responses for either group, with or
without lesions. Additionally, in 2006, researchers found an
increased GIN test threshold for the ear contralateral to the
lesion in only three cases and bilaterally in five cases (5).
The results of a recent study revealed that no significant
differences existed between the right and the left ears in
either normal individuals or MTS patients. According to the
authors, this finding could suggest that MTS makes the
central nervous system vulnerable to temporal processing
deficits (12). Contralateral seizure propagation in patients
with mesial temporal lobe epilepsy has also been reported in
the literature, indicating that the condition may affect both
sides (24).
These results are probably related to the fact that the
response to the GIN test involves the whole cortex, and not
only its contralateral pathways (3).
Clinical Decision Analysis
Sensitivity and specificity indices were calculated based on
the performance of the subjects in the present study
(Figures 1 and 2). ROC curves indicated that a 6.8 ms cut-
off for the GDTh and a 68% cut-off for the percentage of
correct responses yielded the best overall balance between
diagnostic indices. At these cut-offs, a sensitivity and a
specificity of 68% and 98%, respectively, were noted for the
GDTh, whereas a sensitivity and a specificity of 81% and
83%, respectively, were noted for the percentage of correct
responses. These findings indicate that the GIN test shows
good efficiency in detecting lesions of the mesial temporal
lobe.
The hit rates for central auditory dysfunction in the present
study are somewhat consistent with what has previously
been noted. Previous results specifically showed a sensitivity
of 67% and a specificity of 94% for a GDTh of 7 ms (3).
Conversely, the ROC curves for the percentage of correct
Figure 2 - Receiver operating characteristic curves for the percentage of correct answers in the gaps-in-noise test, comparing the right
and left ears in the normal and neurological groups.
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responses were slightly different between the present study
and the previous results in the literature (3). The differences
between the studies may have been influenced by the
differences in age and lesion sites between the study
samples. More specifically, the mean age in Musiek’s
study (3) was higher than that in the current study, and that
study’s subjects had more extensive lesions than in the
present study; the lesions ranged from the brainstem to
the right and left hemispheres, rather than being restricted to
the auditory cortex.
Auditory Contributions from the Mesial
Temporal Lobe
The regions affected by MTS can be relatively diffuse. In
patients with this condition, several authors have noted that
abnormalities are associated with one or more of the
following regions: the hippocampus, temporal neocortex,
insula, uncus, precentral gyrus, thalamus, parietal lobe,
cuneus, and cingulum. Individuals with severe seizure
conditions also show abnormalities in the temporal and
extratemporal lobes (25,26). Furthermore, fMRI data have
indicated that MTS decreases the functional connectivity
between auditory regions and other sensory areas of the
cerebrum such as somatosensory areas (27).
Despite the diffuse nature of these lesions, multiple
studies, including the present investigation, have noted poor
performance on auditory measures in patients with MTS. In
2011, one study showed that individuals with MTS exhibited
significantly elevated auditory electrophysiological thresh-
olds, as measured based on the auditory steady-state
response compared with controls, even though the two
groups had similar behavioral thresholds (28). This result
suggests that the neural function of MTS patients does not
contribute the neural synchrony necessary for the detection
of subtle electrophysiological events. This finding was
further supported by studies showing electrophysiologic
abnormalities in event-related potentials (ERPs) recorded
from patients with MTS (29), which were not observed using
a similar paradigm in the visual modality (30).
The current study extends this area of knowledge to
suggest that in addition to having dysfunction in the central
auditory system, functional difficulties are observed in the
encoding of rapid changes in the fine structure of the
auditory signal in patients with MTS. This finding supports
previous research suggesting reduced gap detection ability
and poor temporal processing in patients with neurological
dysfunction of the central auditory system (3,5).
Clinical Implications
The present study supports the utility of the GIN test in
patients with MTS. Furthermore, the findings presented here
support previous investigations indicating that the GIN test,
and gap detection ability more generally, is a sensitive and
specific measure of CANS dysfunction. The lack of an ear
effect in the present study suggests the possibility of testing a
single ear or administering the GIN test bilaterally when
using the measure clinically. However, the latter approach
would require validation in a neurological population before
widespread clinical use.
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